ParkinsonFranceV1, Hal, Corpus, bibRecord, 000256

Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis

Identifieur interne : 000256 ( Hal/Corpus ); précédent : 000255; suivant : 000257

Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis

Auteurs : Tomasz Fundament ; Paul R. Eldridge ; Alexander L. Green ; Alan L. Whone ; Rod S. Taylor ; Adrian C. Williams ; W. M. Michael Schuepbach

Source :

PLoS ONE [ 1932-6203 ] ; 2016-07-21.

RBID : Hal:hal-01375729

Abstract

Background: Parkinson’s disease (PD) is a debilitating illness associated with considerable impairment of quality of life and substantial costs to health care systems. Deep brain stimulation (DBS) is an established surgical treatment option for some patients with advanced PD. The EARLYSTIM trial has recently demonstrated its clinical benefit also in patients with early motor complications. We sought to evaluate the cost-effectiveness of DBS, compared to best medical therapy (BMT), among PD patients with early onset of motor complications, from a United Kingdom (UK) payer perspective.Methods: We developed a Markov model to represent the progression of PD as rated using the Unified Parkinson's Disease Rating Scale (UPDRS) over time in patients with early PD. Evidence sources were a systematic review of clinical evidence; data from the EARLYSTIM study; and a UK Clinical Practice Research Datalink (CPRD) dataset including DBS patients. A mapping algorithm was developed to generate utility values based on UPDRS data for each intervention. The cost-effectiveness was expressed as the incremental cost per quality-adjusted life-year (QALY). One-way and probabilistic sensitivity analyses were undertaken to explore the effect of parameter uncertainty.Results: Over a 15-year time horizon, DBS was predicted to lead to additional mean cost per patient of £26,799 compared with BMT (£73,077/patient versus £46,278/patient) and an additional mean 1.35 QALYs (6.69 QALYs versus 5.35 QALYs), resulting in an incremental cost-effectiveness ratio of £19,887 per QALY gained with a 99% probability of DBS being cost-effective at a threshold of £30,000/QALY. One-way sensitivity analyses suggested that the results were not significantly impacted by plausible changes in the input parameter values.Conclusion: These results indicate that DBS is a cost-effective intervention in PD patients with early motor complications when compared with existing interventions, offering additional health benefits at acceptable incremental cost. This supports the extended use of DBS among patients with early onset of motor complications.

Url:

http://hal.upmc.fr/hal-01375729

DOI: 10.1371/journal.pone.0159340

Links to Exploration step

Hal:hal-01375729

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis</title>
<author><name sortKey="Fundament, Tomasz" sort="Fundament, Tomasz" uniqKey="Fundament T" first="Tomasz" last="Fundament">Tomasz Fundament</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-467813" status="INCOMING">  <orgName>HTA Consulting, Krakow</orgName>
  <desc>    <address>      <country key="PL"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Eldridge, Paul R" sort="Eldridge, Paul R" uniqKey="Eldridge P" first="Paul R." last="Eldridge">Paul R. Eldridge</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-447404" status="INCOMING">  <orgName>The Walton Centre NHS Foundation Trust</orgName>
  <desc>    <address>      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Green, Alexander L" sort="Green, Alexander L" uniqKey="Green A" first="Alexander L." last="Green">Alexander L. Green</name>
<affiliation><hal:affiliation type="laboratory" xml:id="struct-99434" status="INCOMING">  <orgName>Nuffield Department of Surgery</orgName>
  <desc>    <address>      <addrLine>Oxford</addrLine>
      <country key="GB"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-302612" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-302612" type="direct"><org type="institution" xml:id="struct-302612" status="VALID">  <orgName>University of Oxford [Oxford]</orgName>
  <desc>    <address>      <addrLine>Wellington Square, Oxford OX1 2JD</addrLine>
      <country key="GB"></country>
    </address>
    <ref type="url">http://www.ox.ac.uk/</ref>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Whone, Alan L" sort="Whone, Alan L" uniqKey="Whone A" first="Alan L." last="Whone">Alan L. Whone</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-467814" status="INCOMING">  <orgName>Bristol Brain Centre</orgName>
  <desc>    <address>      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Taylor, Rod S" sort="Taylor, Rod S" uniqKey="Taylor R" first="Rod S." last="Taylor">Rod S. Taylor</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-460277" status="INCOMING">  <orgName> University of Exeter Medical School</orgName>
  <desc>    <address>      <addrLine>Exeter EX2 5DW</addrLine>
      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Williams, Adrian C" sort="Williams, Adrian C" uniqKey="Williams A" first="Adrian C." last="Williams">Adrian C. Williams</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-467831" status="INCOMING">  <orgName>University Hospitals Birmingham NHS Foundation Trust</orgName>
  <desc>    <address>      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Schuepbach, W M Michael" sort="Schuepbach, W M Michael" uniqKey="Schuepbach W" first="W. M. Michael" last="Schuepbach">W. M. Michael Schuepbach</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-236940" status="VALID">  <orgName>Universität Bern [Bern]</orgName>
  <desc>    <address>      <addrLine>Hochschulstrasse 4 - CH-3012 Bern</addrLine>
      <country key="CH"></country>
    </address>
    <ref type="url">http://www.unibe.ch/eng/</ref>
  </desc>
</hal:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01375729</idno>
<idno type="halId">hal-01375729</idno>
<idno type="halUri">http://hal.upmc.fr/hal-01375729</idno>
<idno type="url">http://hal.upmc.fr/hal-01375729</idno>
<idno type="doi">10.1371/journal.pone.0159340</idno>
<date when="2016-07-21">2016-07-21</date>
<idno type="wicri:Area/Hal/Corpus">000256</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis</title>
<author><name sortKey="Fundament, Tomasz" sort="Fundament, Tomasz" uniqKey="Fundament T" first="Tomasz" last="Fundament">Tomasz Fundament</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-467813" status="INCOMING">  <orgName>HTA Consulting, Krakow</orgName>
  <desc>    <address>      <country key="PL"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Eldridge, Paul R" sort="Eldridge, Paul R" uniqKey="Eldridge P" first="Paul R." last="Eldridge">Paul R. Eldridge</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-447404" status="INCOMING">  <orgName>The Walton Centre NHS Foundation Trust</orgName>
  <desc>    <address>      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Green, Alexander L" sort="Green, Alexander L" uniqKey="Green A" first="Alexander L." last="Green">Alexander L. Green</name>
<affiliation><hal:affiliation type="laboratory" xml:id="struct-99434" status="INCOMING">  <orgName>Nuffield Department of Surgery</orgName>
  <desc>    <address>      <addrLine>Oxford</addrLine>
      <country key="GB"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-302612" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-302612" type="direct"><org type="institution" xml:id="struct-302612" status="VALID">  <orgName>University of Oxford [Oxford]</orgName>
  <desc>    <address>      <addrLine>Wellington Square, Oxford OX1 2JD</addrLine>
      <country key="GB"></country>
    </address>
    <ref type="url">http://www.ox.ac.uk/</ref>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Whone, Alan L" sort="Whone, Alan L" uniqKey="Whone A" first="Alan L." last="Whone">Alan L. Whone</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-467814" status="INCOMING">  <orgName>Bristol Brain Centre</orgName>
  <desc>    <address>      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Taylor, Rod S" sort="Taylor, Rod S" uniqKey="Taylor R" first="Rod S." last="Taylor">Rod S. Taylor</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-460277" status="INCOMING">  <orgName> University of Exeter Medical School</orgName>
  <desc>    <address>      <addrLine>Exeter EX2 5DW</addrLine>
      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Williams, Adrian C" sort="Williams, Adrian C" uniqKey="Williams A" first="Adrian C." last="Williams">Adrian C. Williams</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-467831" status="INCOMING">  <orgName>University Hospitals Birmingham NHS Foundation Trust</orgName>
  <desc>    <address>      <country key="GB"></country>
    </address>
  </desc>
</hal:affiliation>
</affiliation>
</author>
<author><name sortKey="Schuepbach, W M Michael" sort="Schuepbach, W M Michael" uniqKey="Schuepbach W" first="W. M. Michael" last="Schuepbach">W. M. Michael Schuepbach</name>
<affiliation><hal:affiliation type="institution" xml:id="struct-236940" status="VALID">  <orgName>Universität Bern [Bern]</orgName>
  <desc>    <address>      <addrLine>Hochschulstrasse 4 - CH-3012 Bern</addrLine>
      <country key="CH"></country>
    </address>
    <ref type="url">http://www.unibe.ch/eng/</ref>
  </desc>
</hal:affiliation>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1371/journal.pone.0159340</idno>
<series><title level="j">PLoS ONE</title>
<idno type="ISSN">1932-6203</idno>
<imprint><date type="datePub">2016-07-21</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Parkinson’s disease (PD) is a debilitating illness associated with considerable impairment of quality of life and substantial costs to health care systems. Deep brain stimulation (DBS) is an established surgical treatment option for some patients with advanced PD. The EARLYSTIM trial has recently demonstrated its clinical benefit also in patients with early motor complications. We sought to evaluate the cost-effectiveness of DBS, compared to best medical therapy (BMT), among PD patients with early onset of motor complications, from a United Kingdom (UK) payer perspective.Methods: We developed a Markov model to represent the progression of PD as rated using the Unified Parkinson's Disease Rating Scale (UPDRS) over time in patients with early PD. Evidence sources were a systematic review of clinical evidence; data from the EARLYSTIM study; and a UK Clinical Practice Research Datalink (CPRD) dataset including DBS patients. A mapping algorithm was developed to generate utility values based on UPDRS data for each intervention. The cost-effectiveness was expressed as the incremental cost per quality-adjusted life-year (QALY). One-way and probabilistic sensitivity analyses were undertaken to explore the effect of parameter uncertainty.Results: Over a 15-year time horizon, DBS was predicted to lead to additional mean cost per patient of £26,799 compared with BMT (£73,077/patient versus £46,278/patient) and an additional mean 1.35 QALYs (6.69 QALYs versus 5.35 QALYs), resulting in an incremental cost-effectiveness ratio of £19,887 per QALY gained with a 99% probability of DBS being cost-effective at a threshold of £30,000/QALY. One-way sensitivity analyses suggested that the results were not significantly impacted by plausible changes in the input parameter values.Conclusion: These results indicate that DBS is a cost-effective intervention in PD patients with early motor complications when compared with existing interventions, offering additional health benefits at acceptable incremental cost. This supports the extended use of DBS among patients with early onset of motor complications.</div>
</front>
</TEI>
<hal api="V3">          <titleStmt>            <title xml:lang="en">Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis</title>
            <author role="aut">              <persName>                <forename type="first">Tomasz</forename>
                <surname>Fundament</surname>
              </persName>
              <idno type="halauthorid">1392776</idno>
              <affiliation ref="#struct-467813"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Paul R.</forename>
                <surname>Eldridge</surname>
              </persName>
              <idno type="halauthorid">1392777</idno>
              <affiliation ref="#struct-447404"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Alexander L.</forename>
                <surname>Green</surname>
              </persName>
              <idno type="halauthorid">1392778</idno>
              <affiliation ref="#struct-99434"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Alan L.</forename>
                <surname>Whone</surname>
              </persName>
              <idno type="halauthorid">1392779</idno>
              <affiliation ref="#struct-467814"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Rod S.</forename>
                <surname>Taylor</surname>
              </persName>
              <idno type="halauthorid">1392780</idno>
              <affiliation ref="#struct-460277"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Adrian C.</forename>
                <surname>Williams</surname>
              </persName>
              <idno type="halauthorid">1392781</idno>
              <affiliation ref="#struct-467831"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">W. M. Michael</forename>
                <surname>Schuepbach</surname>
              </persName>
              <idno type="halauthorid">1392782</idno>
              <affiliation ref="#struct-236940"></affiliation>
              <affiliation ref="#struct-246044"></affiliation>
              <affiliation ref="#struct-2623"></affiliation>
            </author>
            <editor role="depositor">              <persName>                <forename>Gestionnaire</forename>
                <surname>HAL-UPMC</surname>
              </persName>
              <email type="md5">6d9ad2d5331d206e4ad27346e79eb6c9</email>
              <email type="domain">upmc.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>            <edition n="v1" type="current">              <date type="whenSubmitted">2016-10-03 14:25:06</date>
              <date type="whenModified">2016-10-04 09:36:18</date>
              <date type="whenReleased">2016-10-03 14:35:38</date>
              <date type="whenProduced">2016-07-21</date>
              <date type="whenEndEmbargoed">2016-10-03</date>
              <ref type="file" target="http://hal.upmc.fr/hal-01375729/document">                <date notBefore="2016-10-03"></date>
              </ref>
              <ref type="file" subtype="publisherPaid" n="1" target="http://hal.upmc.fr/hal-01375729/file/journal.pone.0159340.PDF">                <date notBefore="2016-10-03"></date>
              </ref>
            </edition>
            <respStmt>              <resp>contributor</resp>
              <name key="320715">                <persName>                  <forename>Gestionnaire</forename>
                  <surname>HAL-UPMC</surname>
                </persName>
                <email type="md5">6d9ad2d5331d206e4ad27346e79eb6c9</email>
                <email type="domain">upmc.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>            <distributor>CCSD</distributor>
            <idno type="halId">hal-01375729</idno>
            <idno type="halUri">http://hal.upmc.fr/hal-01375729</idno>
            <idno type="halBibtex">fundament:hal-01375729</idno>
            <idno type="halRefHtml">PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0159340. <10.1371/journal.pone.0159340></idno>
            <idno type="halRef">PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0159340. <10.1371/journal.pone.0159340></idno>
            <availability status="restricted">              <licence target="http://creativecommons.org/licenses/by/">Attribution</licence>
            </availability>
          </publicationStmt>
          <seriesStmt>            <idno type="stamp" n="UPMC">Université Pierre et Marie Curie</idno>
            <idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" p="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="ICM" p="UPMC">Institut du Cerveau et de la Moëlle Epinière</idno>
            <idno type="stamp" n="APHP" p="INSERM">AP-HP</idno>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
          </seriesStmt>
          <notesStmt>            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>            <biblStruct>              <analytic>                <title xml:lang="en">Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis</title>
                <author role="aut">                  <persName>                    <forename type="first">Tomasz</forename>
                    <surname>Fundament</surname>
                  </persName>
                  <idno type="halauthorid">1392776</idno>
                  <affiliation ref="#struct-467813"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Paul R.</forename>
                    <surname>Eldridge</surname>
                  </persName>
                  <idno type="halauthorid">1392777</idno>
                  <affiliation ref="#struct-447404"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Alexander L.</forename>
                    <surname>Green</surname>
                  </persName>
                  <idno type="halauthorid">1392778</idno>
                  <affiliation ref="#struct-99434"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Alan L.</forename>
                    <surname>Whone</surname>
                  </persName>
                  <idno type="halauthorid">1392779</idno>
                  <affiliation ref="#struct-467814"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Rod S.</forename>
                    <surname>Taylor</surname>
                  </persName>
                  <idno type="halauthorid">1392780</idno>
                  <affiliation ref="#struct-460277"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Adrian C.</forename>
                    <surname>Williams</surname>
                  </persName>
                  <idno type="halauthorid">1392781</idno>
                  <affiliation ref="#struct-467831"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">W. M. Michael</forename>
                    <surname>Schuepbach</surname>
                  </persName>
                  <idno type="halauthorid">1392782</idno>
                  <affiliation ref="#struct-236940"></affiliation>
                  <affiliation ref="#struct-246044"></affiliation>
                  <affiliation ref="#struct-2623"></affiliation>
                </author>
              </analytic>
              <monogr>                <idno type="halJournalId" status="VALID">28700</idno>
                <idno type="issn">1932-6203</idno>
                <title level="j">PLoS ONE</title>
                <imprint>                  <publisher>Public Library of Science</publisher>
                  <biblScope unit="volume">11</biblScope>
                  <biblScope unit="issue">7</biblScope>
                  <biblScope unit="pp">e0159340</biblScope>
                  <date type="datePub">2016-07-21</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1371/journal.pone.0159340</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>            <langUsage>              <language ident="en">English</language>
            </langUsage>
            <textClass>              <classCode scheme="halDomain" n="sdv.neu">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]</classCode>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">Background: Parkinson’s disease (PD) is a debilitating illness associated with considerable impairment of quality of life and substantial costs to health care systems. Deep brain stimulation (DBS) is an established surgical treatment option for some patients with advanced PD. The EARLYSTIM trial has recently demonstrated its clinical benefit also in patients with early motor complications. We sought to evaluate the cost-effectiveness of DBS, compared to best medical therapy (BMT), among PD patients with early onset of motor complications, from a United Kingdom (UK) payer perspective.Methods: We developed a Markov model to represent the progression of PD as rated using the Unified Parkinson's Disease Rating Scale (UPDRS) over time in patients with early PD. Evidence sources were a systematic review of clinical evidence; data from the EARLYSTIM study; and a UK Clinical Practice Research Datalink (CPRD) dataset including DBS patients. A mapping algorithm was developed to generate utility values based on UPDRS data for each intervention. The cost-effectiveness was expressed as the incremental cost per quality-adjusted life-year (QALY). One-way and probabilistic sensitivity analyses were undertaken to explore the effect of parameter uncertainty.Results: Over a 15-year time horizon, DBS was predicted to lead to additional mean cost per patient of £26,799 compared with BMT (£73,077/patient versus £46,278/patient) and an additional mean 1.35 QALYs (6.69 QALYs versus 5.35 QALYs), resulting in an incremental cost-effectiveness ratio of £19,887 per QALY gained with a 99% probability of DBS being cost-effective at a threshold of £30,000/QALY. One-way sensitivity analyses suggested that the results were not significantly impacted by plausible changes in the input parameter values.Conclusion: These results indicate that DBS is a cost-effective intervention in PD patients with early motor complications when compared with existing interventions, offering additional health benefits at acceptable incremental cost. This supports the extended use of DBS among patients with early onset of motor complications.</abstract>
          </profileDesc>
        </hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000256 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Hal/Corpus/biblio.hfd -nk 000256 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Hal
   |étape=   Corpus
   |type=    RBID
   |clé=     Hal:hal-01375729
   |texte=   Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis

Deep Brain Stimulation for Parkinson’s Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri